This study will compare the role of two drugs namely levetiracetam and sodium valproate in managing childhood epilepsy
Phase 2
- Conditions
- Health Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes
- Registration Number
- CTRI/2024/08/071841
- Lead Sponsor
- Pandit bhagwat Dayal Sharma postgraduate institute of medical sciences rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Children aged 2-14 years with New diagnosed epilepsy
Exclusion Criteria
1.Age less than 2 and more than 14 years
2.Simple febrile seizure
3.Seizure secondary to other condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the frequency of repeat seizure at 3 months post treatment in valproate and levetiracetam groupTimepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method To see the adverse effects of both these drugs -levetiracetam & sodium valproateTimepoint: 12 weeks